Clinical TrialsZalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Zalfermin Fails to Add Fibrosis Benefit to Semaglutide in Phase 2 MASH Tria... Read Post »
Clinical TrialsMepolizumab Improves Disease Control and Moves Patients Toward Remission in... Mepolizumab Improves Disease Control and Moves Patients Toward Remission in... Read Post »
Health TidingsRein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Rein Therapeutics Receives FDA Fast Track Designation for LTI-03 in Idiopat... Read Post »
Health Tidings Mergers & AcquisitionsChai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Chai Discovery and Bristol Myers Squibb Partner to Advance AI-Driven Antibo... Read Post »
Clinical TrialsCan Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Can Lower-Dose Aspirin Reduce Cancer Risk in People With Lynch Syndrome? Ca... Read Post »
Health TidingsNuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Nuvation Bio’s Safusidenib Receives FDA Fast Track Designation in IDH1-Mu... Read Post »
Health Tidings Mergers & AcquisitionsTolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Tolerance Bio Advances Efineptakin Alfa into Phase 2 Development for Thymic... Read Post »
Health TidingsFDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... FDA Details Clinical Evidence Supporting ASCENIV Expansion to Children Aged... Read Post »
Clinical TrialsPositive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Positive Phase 1 Findings Put AC Immune’s Brain-Penetrant NLRP3 Inhib... Read Post »
Clinical TrialsLeads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Leads Biolabs’ LBL-024 (Opamtistomig) Shows 65% Response Rate in First-Li... Read Post »
GenericsGlenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Glenmark Wins U.S. FDA Approval for Fluticasone Propionate Nasal Spray Read Post »
New Drug ApprovalUltragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Ultragenyx’s GENGLYCOS Receives FDA Accelerated Approval as First Treatme... Read Post »
New Drug ApprovalRegeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Regeneron Wins FDA Approval for Pasatru to Reduce New Bone Formation in Adu... Read Post »
Clinical TrialsArcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Arcato’s Three-Anesthetic Cocktail Shows Safety and Early Analgesic Activ... Read Post »
Health TidingsKaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... KaliVir Raises $14 Million to Advance VET3-TGI in Phase 1/1b Solid Tumor Tr... Read Post »
Health TidingsFDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... FDA Accepts Teva’s NDA for Ecopipam with Priority Review for Pediatric To... Read Post »
Health TidingsConsano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Consano Bio’s C-1101 Wins FDA Fast Track for Chronic Sciatica Read Post »
Health Tidings Mergers & AcquisitionsFulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Fulcrum-Slate Merger Creates New Platform to Advance Next-Generation Migrai... Read Post »
Health TidingsKynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Kynexis Advances KYN-5356 Toward Registrational Development in Schizophreni... Read Post »
Health Tidings Mergers & AcquisitionsIDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC IDEAYA and Genentech Partner to Evaluate IDE892 Plus GDC-7035 in PDAC Read Post »
Clinical TrialsModerna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Moderna-Merck’s Intismeran Plus KEYTRUDA Shows Positive Phase 3 Resul... Read Post »
ResearchCan Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Can Risdiplam Sustain Survival and Motor Function in Children with Type 1 S... Read Post »
Health TidingsAbcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Abcuro Raises $66M Series D for Ulviprubart IBM Phase 3 Trial Read Post »
Clinical TrialsCould Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Could Once-Weekly IcoSema Offer a New Approach to Insulin Treatment in Type... Read Post »
Health Tidings Mergers & AcquisitionsChugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Chugai’s AID351 Anti-Dengue Antibody Licensed to GSK for Clinical Develop... Read Post »
Health Tidings Mergers & AcquisitionsBioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... BioMarin to Acquire Alesta Therapeutics for $275 Million Upfront to Advance... Read Post »
Clinical TrialsCan B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Can B7-H3-Targeted CAR-T Therapy Open a New Treatment Path for Recurrent Gl... Read Post »
Health TidingsAVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... AVITA Medical Reports PermeaDerm Study Results Showing 70% Lower Treatment ... Read Post »
Clinical TrialsCan the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Can the Chemistry of Exercise Be Delivered in a Daily Pill? Enveda Advances... Read Post »
Health TidingsEvaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Evaxion Shifts Cancer Vaccine Focus to Glioblastoma With EVX-05 Following E... Read Post »
Health Tidings Mergers & AcquisitionsLEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... LEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... Read Post »
Health TidingsBlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... BlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
ResearchCan Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Can Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Read Post »
Health TidingsEli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Eli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
GenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Biocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Read Post »
Health TidingsFDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... FDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... Read Post »
Health TidingsFate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Fate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Read Post »
Mergers & AcquisitionsOmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... OmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... Read Post »
Health TidingsEyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD EyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD Read Post »
Health TidingsGalmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Galmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Read Post »
Health TidingsSpevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Spevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Read Post »
Health TidingsEnhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Enhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Read Post »
Health TidingsMHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour MHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour Read Post »
Clinical Trialsargenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... argenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... Read Post »
Health TidingsAbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... AbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... Read Post »
Clinical TrialsAstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... Read Post »
Health TidingsPfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Pfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Read Post »
